MCL restrained ROS/AKT/ASAH1 pathway to therapy tamoxifen resistance breast cancer by stabilizing NRF2

Abstract

Tamoxifen resistance is a common and difficult problem in the clinical treatment of breast cancer (BC). As a novel antitumor agent, Micheliolide (MCL) has shown a better therapeutic effect on tumours; however, little is known about MCL and its role in BC therapy. With tamoxifen stimulation, drug-resistant BC cells MCF7TAMR and T47DTAMR obtained a high oxidative status and Amidohydrolase 1 (ASAH1) was abnormally activated. The inhibition of ASAH1 rescued the sensitivity of resistant cells to tamoxifen. We found that MCL inhibited the expression of ASAH1 and cell proliferation, especially in MCF7TAMR and T47DTAMR cells. The high oxidative stress status of resistant cells stimulated the expression of ASAH1 by positively regulating AKT, which was restrained by MCL. MCL activated NRF2 by directly binding to KEAP1 and promoting the antioxidant level of tamoxifen-resistant (TAMR) cells. In addition, ACT001, the prodrug of MCL, significantly inhibited the tumour growth of TAMR cells in preclinical xenograft tumour models. In conclusion, ASAH1 mediates tamoxifen resistance in ER-positive BC cells. MCL could activate the cellular antioxidant system via NRF2/KEAP1 and inhibit ASAH1 expression through the ROS/AKT signalling pathway, thus suppressing cell proliferation. MCL could be used as a potential treatment for TAMR-BC.

References

[1] MishraA, Srivastava A, PateriyaA, TomarMS, MishraAK, ShrivastavaA. Metabolic reprograming confers tamoxifen resistance in breast cancer. Chem Biol Interact. 2021;347:109602.

[2] OsborneCK, SchiffR. Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancer. Breast. 2003;12(6):362-367.

[3] LeghaSS. Tamoxifen in the treatment of breast cancer. Ann Intern Med. 1988;109(3):219-228.

[4] PrasadS, GuptaSC, TyagiAK. Reactive oxygen species (ROS) and cancer: role of antioxidative nutraceuticals. Cancer Lett. 2017;387:95-105.

[5] GaladariS, RahmanA, PallichankandyS, ThayyullathilF. Reactive oxygen species and cancer paradox: to promote or to suppress? Free Radic Biol Med. 2017;104:144-164.

[6] LobodaA, Damulewicz M, PyzaE, JozkowiczA, DulakJ. Role of Nrf2/HO-1 system in development, oxidative stress response and diseases: an evolutionarily conserved mechanism. Cell Mol Life Sci. 2016;73(17):3221-3247.

[7] HuangS, WangH, ChenW, et al. Tamoxifen inhibits cell proliferation by impaired glucose metabolism in gallbladder cancer. J Cell Mol Med. 2020;24(2):1599-1613.

[8] HlaT. Signaling and biological actions of sphingosine 1-phosphate. Pharmacol Res. 2003;47(5):401-407.

[9] VethakanrajHS, BabuTA, SudarsananGB, DuraisamyPK, Ashok Kumar S. Targeting ceramide metabolic pathway induces apoptosis in human breast cancer cell lines. Biochem Biophys Res Commun. 2015;464(3):833-839.

[10] HawkinsCC, JonesAB, GordonER, et al. Targeting acid ceramidase inhibits glioblastoma cell migration through decreased AKT signaling. Cells. 2022;11(12):1873.

[11] GovindarajahN, Clifford R, BowdenD, SuttonPA, Parsons JL, VimalachandranD. Sphingolipids and acid ceramidase as therapeutic targets in cancer therapy. Crit Rev Oncol Hematol. 2019;138:104-111.

[12] XiaoJ, ZengW, ZhangP, Zhou Y, FangQ. Acid ceramidase targeting pyruvate kinase affected trypsinogen activation in acute pancreatitis. Mol Med. 2022;28(1):106.

[13] MalviP, Janostiak R, NagarajanA, ZhangX, Wajapeyee N. N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production. Mol Metab. 2021;48:101217.

[14] LiuQ, GuoX, HuangZ, et al. Anti-neuroinflammatory effects of dimethylaminomylide (DMAMCL, i.e., ACT001) are associated with attenuating the NLRP3 in fl ammasome in MPTP-induced Parkinson disease in mice. Behav Brain Res. 2020;383:112539.

[15] DongY, QianX, LiJ. Sesquiterpene lactones and cancer: new insight into antitumor and anti-inflammatory effects of parthenolide-derived dimethylaminomicheliolide and micheliolide. Comput Math Methods Med. 2022;2022:3744837.

[16] YaoS, YeJ, YinM, YuR. DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo. Cancer Lett. 2020;483:87-97.

[17] XuN, HuaZ, BaG, et al. The anti-tumor growth effect of a novel agent DMAMCL in rhabdomyosarcoma in vitro and in vivo. J Exp Clin Cancer Res. 2019;38(1):118.

[18] TsoiH, YouCP, LeungMH, Man EPS, KhooUS. Targeting ribosome biogenesis to combat tamoxifen resistance in ER+ve breast cancer. Cancers (Basel). 2022;14(5):1251.

[19] ParveenF, BenderD, LawSH, Mishra VK, ChenCC, KeLY. Role of ceramidases in sphingolipid metabolism and human diseases. Cells. 2019;8(12):1573.

[20] DrexlerY, MolinaJ, MitrofanovaA, FornoniA, Merscher S. Sphingosine-1-phosphate metabolism and signaling in kidney diseases. J Am Soc Nephrol. 2021;32(1):9-31.

[21] BadiaE, MorenaM, LauretC, et al. Effect of tamoxifen and fulvestrant long-term treatments on ROS production and (pro/anti)-oxidant enzymes mRNA levels in a MCF-7-derived breast cancer cell line. Breast Cancer. 2016;23(5):692-700.

[22] WangY, QiH, LiuY, et al. The double-edged roles of ROS in cancer prevention and therapy. Theranostics. 2021;11(10):4839-4857.

[23] KleihM, BoppleK, DongM, et al. Direct impact of cisplatin on mitochondria induces ROS production that dictates cell fate of ovarian cancer cells. Cell Death Dis. 2019;10(11):851.

[24] HanM, WangB, SongG, Shi S. Comparative study of alleviation effects of DMTU and PCIB on root growth inhibition in two tall fescue varieties under cadmium stress. Ecotoxicol Environ Saf. 2020;196:110528.

[25] BarrioE, VecinoR, Sanchez-MoranI, et al. Preconditioning-activated AKT controls neuronal tolerance to ischemia through the MDM2-p53 pathway. Int J Mol Sci. 2021;22(14):7275.

[26] LvG, WangW, SunM, WangF, MaY, LiC. Inhibiting specificity protein 1 attenuated sevoflurane-induced mitochondrial stress and promoted autophagy in hippocampal neurons through PI3K/Akt/mTOR and alpha7-nAChR signaling. Neurosci Lett. 2023;794:136995.

[27] DementievA, Joachimiak A, NguyenH, et al. Molecular mechanism of inhibition of acid ceramidase by carmofur. J Med Chem. 2019;62(2):987-992.

[28] PizziraniD, BachA, RealiniN, et al. Benzoxazolone carboxamides: potent and systemically active inhibitors of intracellular acid ceramidase. Angew Chem Int ed Engl. 2015;54(2):485-489.

[29] WangD, WangC, WangL, Chen Y. A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment. Drug Deliv. 2019;26(1):551-565.

[30] GuoJ, LiuK, WangJ, et al. A rational foundation for micheliolide-based combination strategy by targeting redox and metabolic circuit in cancer cells. Biochem Pharmacol. 2022;200:115037.

[31] ZhangJ, ChenY, FangJ. Targeting thioredoxin reductase by micheliolide contributes to radiosensitizing and inducing apoptosis of HeLa cells. Free Radic Biol Med. 2022;186:99-109.

[32] HuC, WuZ, HuangZ, et al. Nox2 impairs VEGF-A-induced angiogenesis in placenta via mitochondrial ROS-STAT3 pathway. Redox Biol. 2021;45:102051.

[33] BaloghE, Chowdhury A, AbabnehH, CsikiDM, TothA, JeneyV. Heme-mediated activation of the Nrf2/HO-1 axis attenuates calcification of valve interstitial cells. Biomedicine. 2021;9(4):427.

[34] LiJ, LiS, GuoJ, et al. Natural product micheliolide (MCL) irreversibly activates pyruvate kinase M2 and suppresses leukemia. J Med Chem. 2018;61(9):4155-4164.

[35] BaillyC. Anticancer targets and signaling pathways activated by britannin and related pseudoguaianolide sesquiterpene lactones. Biomedicine. 2021;9(10):1325.

[36] WangM, LiuCY, WangT, et al. (+)-Clausenamide protects against drug-induced liver injury by inhibiting hepatocyte ferroptosis. Cell Death Dis. 2020;11(9):781.

[37] HourihanJM, KennaJG, HayesJD. The gasotransmitter hydrogen sulfide induces nrf2-target genes by inactivating the keap1 ubiquitin ligase substrate adaptor through formation of a disulfide bond between cys-226 and cys-613. Antioxid Redox Signal. 2013;19(5):465-481.

[38] WuG, ZhuL, YuanX, et al. Britanin ameliorates cerebral ischemia-reperfusion injury by inducing the Nrf2 protective pathway. Antioxid Redox Signal. 2017;27(11):754-768.

[39] PoirotM, Silvente-Poirot S, WeichselbaumRR. Cholesterol metabolism and resistance to tamoxifen. Curr Opin Pharmacol. 2012;12(6):683-689.

[40] RohJL, ParkJY, KimEH, Jang HJ. Targeting acid ceramidase sensitises head and neck cancer to cisplatin. Eur J Cancer. 2016;52:163-172.

[41] DoanNB, NguyenHS, Al-GizawiyMM, et al. Acid ceramidase confers radioresistance to glioblastoma cells. Oncol Rep. 2017;38(4):1932-1940.

[42] ChengJC, BaiA, BeckhamTH, et al. Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse. J Clin Invest. 2013;123(10):4344-4358.

[43] BeckhamTH, ChengJC, LuP, Marrison ST, NorrisJS, LiuX. Acid ceramidase promotes nuclear export of PTEN through sphingosine 1-phosphate mediated Akt signaling. PLoS One. 2013;8(10):e76593.

[44] ZhaoY, HuX, LiuY, et al. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16(1):79.

[45] PenneyRB, RoyD. Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer. Biochim Biophys Acta. 2013;1836(1):60-79.

[46] LiQ, SunY, LiuB, et al. ACT001 modulates the NF-kappaB/MnSOD/ROS axis by targeting IKKbeta to inhibit glioblastoma cell growth. J Mol Med (Berl). 2020;98(2):263-277.

[47] YamamotoM, Kensler TW, MotohashiH. The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis. Physiol Rev. 2018;98(3):1169-1203.

[48] UlasovAV, Rosenkranz AA, GeorgievGP, SobolevAS. Nrf2/Keap1/ARE signaling: towards specific regulation. Life Sci. 2022;291:120111.

[49] BairdL, Yamamoto M. The molecular mechanisms regulating the KEAP1-NRF2 pathway. Mol Cell Biol. 2020;40(13):e00099-20.

[50] NaHK, SurhYJ. Oncogenic potential of Nrf2 and its principal target protein heme oxygenase-1. Free Radic Biol Med. 2014;67:353-365.

[51] TsaiCF, ChenJH, ChangCN, et al. Fisetin inhibits cell migration via inducing HO-1 and reducing MMPs expression in breast cancer cell lines. Food Chem Toxicol. 2018;120:528-535.

[52] LuMC, JiJA, JiangZY, You QD. The Keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med Res Rev. 2016;36(5):924-963.

[53] XiangJ, DingY, LiJ, et al. Ovatodiolides: scalable protection-free syntheses, configuration determination, and biological evaluation against hepatic cancer stem cells. Angew Chem Int Ed Engl. 2019;58(31):10587-10590.

[54] HerdianaY, Sriwidodo S, SofianFF, WilarG, Diantini A. Nanoparticle-based antioxidants in stress signaling and programmed cell death in breast cancer treatment. Molecules. 2023;28(14):5305.

[55] DidierAJ, StieneJ, FangL, Watkins D, DworkinLD, CreedenJF. Antioxidant and anti-tumor effects of dietary vitamins A, C, and E. Antioxidants (Basel). 2023;12(3):632.

[56] KashifM, YaoH, SchmidtS, et al. ROS-lowering doses of vitamins C and A accelerate malignant melanoma metastasis. Redox Biol. 2023;60:102619.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.